10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,791 | -25.8% | 1,304 | +0.4% | 0.00% | – |
| Q2 2023 | $72,537 | +18.0% | 1,299 | +17.9% | 0.00% | – |
| Q1 2023 | $61,481 | +18.5% | 1,102 | -22.6% | 0.00% | – |
| Q4 2022 | $51,890 | -16.3% | 1,424 | -35.0% | 0.00% | – |
| Q3 2022 | $62,000 | -25.3% | 2,192 | +19.3% | 0.00% | – |
| Q2 2022 | $83,000 | -46.5% | 1,838 | -10.2% | 0.00% | – |
| Q1 2022 | $155,000 | +278.0% | 2,046 | +617.9% | 0.00% | – |
| Q4 2021 | $41,000 | +78.3% | 285 | +70.7% | 0.00% | – |
| Q3 2021 | $23,000 | -50.0% | 167 | -28.0% | 0.00% | – |
| Q2 2021 | $46,000 | +12.2% | 232 | +4.0% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 223 | +21.2% | 0.00% | – |
| Q4 2020 | $25,000 | +257.1% | 184 | +201.6% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 61 | +24.5% | 0.00% | – |
| Q2 2020 | $4,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |